Medtronic names Hooman Hakami, the former chief of GE Healthcare’s detection & guidance business, to lead its diabetes unit. Medtronic (NYSE:MDT) said today that it named a former GE Healthcare (NYSE:GE) executive, Hooman Hakami, as president of its global diabetes group. Hakami was president & CEO of GE Healthcare’s $2 billion detection & guidance systems business and led its interventional systems business from 2009 to 2012, according to a press release. Medtronic’s diabetes business put up $1.53 billion in revenues during its last fiscal year ending April 26, 2013.
Help employers find you! Check out all the jobs and post your resume.
